lilly retatrutide trial The numbers from Lilly's Phase 3 dropped this week and I haven't been able to stop thinking about them. Not only as a doctor but as a long-term GLP-1 user eli lilly phase 3 trial
Description
Some individuals with favorable genetic profiles discontinue tirzepatide successfully with standard 8-week tapers
+ 6.5), were also reported [146]
[DOI] [PubMed] [Google Scholar] 8.Zhu Y., Bai J., Zhang Y., Xiao X., Dong Y
Beyond that a shorter average life span of taste buds became evident
Maintain balanced nutrition
however, these results come from a single early-phase trial and cannot be directly compared with approved therapies in the absence of head-to-head studies
